BEAM
Price
$20.01
Change
+$0.13 (+0.65%)
Updated
Jul 3 closing price
Capitalization
2.01B
36 days until earnings call
GLSI
Price
$10.03
Change
+$0.15 (+1.52%)
Updated
Jul 3 closing price
Capitalization
134.08M
35 days until earnings call
Interact to see
Advertisement

BEAM vs GLSI

Header iconBEAM vs GLSI Comparison
Open Charts BEAM vs GLSIBanner chart's image
Beam Therapeutics
Price$20.01
Change+$0.13 (+0.65%)
Volume$1.36M
Capitalization2.01B
Greenwich LifeSciences
Price$10.03
Change+$0.15 (+1.52%)
Volume$31.42K
Capitalization134.08M
BEAM vs GLSI Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. GLSI commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and GLSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BEAM: $20.01 vs. GLSI: $10.03)
Brand notoriety: BEAM and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 70% vs. GLSI: 82%
Market capitalization -- BEAM: $2.01B vs. GLSI: $134.08M
BEAM [@Biotechnology] is valued at $2.01B. GLSI’s [@Biotechnology] market capitalization is $134.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • GLSI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than GLSI.

Price Growth

BEAM (@Biotechnology) experienced а +16.74% price change this week, while GLSI (@Biotechnology) price change was +12.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.01B) has a higher market cap than GLSI($134M). GLSI YTD gains are higher at: -10.686 vs. BEAM (-19.315). GLSI has higher annual earnings (EBITDA): -16.75M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. GLSI (2.75M). BEAM has higher revenues than GLSI: BEAM (63.6M) vs GLSI (0).
BEAMGLSIBEAM / GLSI
Capitalization2.01B134M1,501%
EBITDA-399.03M-16.75M2,382%
Gain YTD-19.315-10.686181%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B2.75M44,364%
Total Debt158MN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMGLSI
RSI
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
77%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 22 days ago
85%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGWRX53.320.65
+1.23%
American Century Growth R
ARCHX18.430.10
+0.55%
Archer Balanced
ARYGX13.390.03
+0.22%
American Century Global Real Estate R5
TIOPX16.640.03
+0.18%
Nuveen International Opps Prem
EIRAX15.120.02
+0.13%
Eaton Vance RBA All Asset Strategy Fd I

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.65%
CRSP - BEAM
72%
Closely correlated
+0.97%
NTLA - BEAM
64%
Loosely correlated
+0.09%
RXRX - BEAM
64%
Loosely correlated
+1.15%
DNLI - BEAM
62%
Loosely correlated
-1.41%
ABSI - BEAM
58%
Loosely correlated
+2.97%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+1.52%
ABOS - GLSI
48%
Loosely correlated
+2.65%
DNLI - GLSI
47%
Loosely correlated
-1.41%
CLDX - GLSI
46%
Loosely correlated
-0.50%
BEAM - GLSI
45%
Loosely correlated
+0.65%
CRSP - GLSI
44%
Loosely correlated
+0.97%
More